RNS Number : 8018E
01 November 2022


(the "Company")

1 November 2022

Total Voting Rights

In conformity with Rule 5.6.1 of the FCA's Disclosure Guidance and Transparency Rules, the Company hereby notifies the market of the following:

As at 31 October 2022, the Company's issued share capital consisted of 1,265,251,105 ordinary shares of £0.005 each ("Ordinary Shares"), 56,082,651 D1 ordinary shares of £0.005 each, 17,741 D2 ordinary shares of £1.00 each, 49,007,865 E ordinary shares of £0.005 each, 27,170,742 F ordinary shares of £0.005 each, 17,560,229 G ordinary shares of £0.005 each, 1 Special Share of £1.00, 313,257 deferred 1 shares of £0.005 each and 21,563,860 deferred 2 shares of £0.005 each. The Company does not hold any shares in treasury.

Only the Ordinary Shares are voting shares and each such Ordinary Share carries one vote per Ordinary Share.

Accordingly, the total number of voting rights in the Company as at 31 October 2022 was 1,265,251,105. This figure may be used by the Company's shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure Guidance and Transparency Rules.


Investor enquiries:


Kate Grimoldby


Media enquiries:

Powerscourt - Financial PR adviser

Tel: +44 (0) 20 7250 1446

Victoria Palmer-Moore/Nick Dibden/Nick Hayns



Viki Tahmasebi





This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.